Gen-Probe Shareholder Aims To Block $3.7B Hologic Deal

A Gen-Probe Inc. shareholder launched a class action in Delaware court on Friday challenging Hologic Inc.'s planned $3.7 billion buyout of the diagnostic-testing company, calling the offer opportunistic and inadequate....

Already a subscriber? Click here to view full article